ABCB11 Gene Cholestasis progressive intrahepatic type 2 Genetic Test
Components: ABCB11 Gene Cholestasis progressive intrahepatic type 2 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ABCB11 Gene Cholestasis progressive intrahepatic type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Cholestasis progressive intrahepatic type 2.
Test Details
ABCB11 Gene Cholestasis progressive intrahepatic type 2 NGS Genetic Test is a genetic test that focuses on the ABCB11 gene, which is associated with a specific type of progressive intrahepatic cholestasis called type 2.
This genetic test uses Next Generation Sequencing (NGS) technology to analyze the DNA sequence of the ABCB11 gene and identify any mutations or variations that may be present.
Progressive intrahepatic cholestasis type 2 is a rare genetic disorder characterized by impaired bile flow within the liver, leading to the buildup of bile acids and other substances in the liver cells. This can result in liver damage and various symptoms such as jaundice, itching, and poor growth.
The ABCB11 gene provides instructions for producing a protein called bile salt export pump (BSEP), which is responsible for transporting bile acids out of liver cells and into the bile ducts. Mutations in the ABCB11 gene can disrupt the function of the BSEP protein, leading to the development of progressive intrahepatic cholestasis type 2.
The NGS genetic test for ABCB11 gene cholestasis progressive intrahepatic type 2 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to analyze the entire coding region of the ABCB11 gene. Any mutations or variations in the gene sequence can be identified and analyzed to determine their potential impact on BSEP function.
The results of this genetic test can help healthcare professionals make a definitive diagnosis of progressive intrahepatic cholestasis type 2 and provide appropriate management and treatment strategies for affected individuals. Additionally, this test can also be used for carrier testing in family members of affected individuals to assess their risk of passing on the condition to future generations.
Test Name | ABCB11 Gene Cholestasis progressive intrahepatic type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ABCB11 Gene Cholestasis progressive intrahepatic type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Cholestasis progressive intrahepatic type 2 |
Test Details |
ABCB11 Gene Cholestasis progressive intrahepatic type 2 NGS Genetic Test is a genetic test that focuses on the ABCB11 gene, which is associated with a specific type of progressive intrahepatic cholestasis called type 2. This genetic test uses Next Generation Sequencing (NGS) technology to analyze the DNA sequence of the ABCB11 gene and identify any mutations or variations that may be present. Progressive intrahepatic cholestasis type 2 is a rare genetic disorder characterized by impaired bile flow within the liver, leading to the buildup of bile acids and other substances in the liver cells. This can result in liver damage and various symptoms such as jaundice, itching, and poor growth. The ABCB11 gene provides instructions for producing a protein called bile salt export pump (BSEP), which is responsible for transporting bile acids out of liver cells and into the bile ducts. Mutations in the ABCB11 gene can disrupt the function of the BSEP protein, leading to the development of progressive intrahepatic cholestasis type 2. The NGS genetic test for ABCB11 gene cholestasis progressive intrahepatic type 2 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to analyze the entire coding region of the ABCB11 gene. Any mutations or variations in the gene sequence can be identified and analyzed to determine their potential impact on BSEP function. The results of this genetic test can help healthcare professionals make a definitive diagnosis of progressive intrahepatic cholestasis type 2 and provide appropriate management and treatment strategies for affected individuals. Additionally, this test can also be used for carrier testing in family members of affected individuals to assess their risk of passing on the condition to future generations. |